Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$374K Sell
7,679
-18
-0.2% -$919 0.3% 95
2026
Q2
$407K Buy
7,697
+409
+6% +$21.6K 0.32% 88
2026
Q1
$406K Buy
7,288
+195
+3% +$10.6K 0.4% 71
2025
Q4
$351K Buy
+7,093
New +$331K 0.35% 85

Other funds holding GSK

JMN Financial's GSK Position: Q3 2026 in Review

JMN Financial reduced its GSK (GSK) stake by 0.23% in Q3 2026, selling an estimated $919 and leaving 7,679 shares worth $374K. The position accounts for 0.3% of the portfolio, ranked #95.

JMN Financial first reported a position in GSK in Q4 2025 and has held it in 4 quarters since. The position peaked at $407K in Q2 2026. 989 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • JMN Financial held 7,679 shares of GSK worth $374K as of Q3 2026.
  • JMN Financial sold 18 GSK shares in Q3 2026, an estimated $919.
  • GSK made up 0.3% of JMN Financial's portfolio in Q3 2026, its #95 holding.
  • JMN Financial first reported a position in GSK in Q4 2025 and has held it in 4 quarters since.
  • JMN Financial's GSK position peaked at $407K in Q2 2026.
  • 989 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on JMN Financial's 13F filing for Q3 2026, filed 10 Nov 2026.